Summary

Japan Plasma Fractionation Market Research Report By Product Type (Immunoglobulin, Albumin, Coagulation Factors, Protease Inhibitors), By Application (Neurology, Hematology, General Medicine, Immunology), By End User (Hospitals, Ambulatory Surgical Centers, Blood Banks, Pharmaceutical Companies) and By Technology (Centrifugation, Chromatography, Precipitation, Filtration) - Growth & Industry Forecast 2025 To 2035

Market Summary:
As per Market Research Future analysis, the Japan plasma fractionation market size was estimated at 1910.0 $ Million in 2024. The Japan plasma fractionation market is projected to grow from 2042.75 $ Million in 2025 to 4000.0 $ Million by 2035, exhibiting a compound annual growth rate (CAGR) of 6.9% during the forecast period 2025 - 2035

Market Drivers:
Supportive government policies in Japan play a vital role in fostering the plasma fractionation market. The Japanese government has implemented various initiatives aimed at promoting research and development in biotechnology and pharmaceuticals. These policies include funding for innovative projects and incentives for companies engaged in plasma fractionation. In 2025, the government is expected to allocate approximately $100 million towards biotechnology research, which could significantly benefit the plasma fractionation market. Furthermore, regulatory frameworks that streamline the approval process for plasma-derived therapies enhance market accessibility. As the government continues to prioritize healthcare innovation, the plasma fractionation market is likely to experience accelerated growth, driven by both public and private sector collaboration. The rising healthcare expenditure in Japan is a pivotal driver for the plasma fractionation market. As the government allocates more funds towards healthcare, the demand for advanced medical treatments, including those derived from plasma, is likely to increase. In 2025, healthcare spending in Japan is projected to reach approximately $500 billion, reflecting a growth rate of around 3% annually.

Market Segment Analysis:
Japan Plasma Fractionation Market Segment Insights Plasma Fractionation Market Product Type Insights The Japan Plasma Fractionation Market is diversified into various product types, primarily including Immunoglobulin, Albumin, Coagulation Factors, and Protease Inhibitors. Each product type plays a crucial role in the healthcare landscape of Japan, supporting therapeutic applications for various diseases. Immunoglobulin, for instance, is vital for treating immune deficiencies, highlighting its importance in the market as the demand for immunotherapy rises. This segment is often recognized for its significant contribution to the treatment of autoimmune disorders and for its use in prophylactic measures against infections. Albumin is another essential component within the Japan Plasma Fractionation Market, serving critical functions in maintaining oncotic pressure and transporting various substances in the blood.

Regional Analysis:
the plasma fractionation market is experiencing notable growth, driven by increasing demand for immunoglobulins and clotting factors.. This demand is largely attributed to the rising prevalence of chronic diseases and the growing awareness of the therapeutic benefits of plasma-derived products. In Japan, advancements in technology and manufacturing processes are enhancing the efficiency of plasma collection and fractionation, thereby improving product availability. Regulatory frameworks are also evolving, ensuring that safety and quality standards are met, which further supports market expansion. Additionally, the aging population in Japan is likely to contribute to a sustained increase in the need for plasma-derived therapies, as older individuals typically require more medical interventions..

Major Players:
The following companies are key participants in the Japan Plasma Fractionation Market, playing a crucial role in market development through technological innovation, strategic partnerships, and competitive product offerings.

ページTOPに戻る

Table of Contents

TABLE OF CONTENT
1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
EXECUTIVE SUMMARY
Market Overview
Key Findings
Market Segmentation
Competitive Landscape
Challenges and Opportunities
Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
MARKET INTRODUCTION
Definition
Scope of the study
Research Objective
Assumption
Limitations
RESEARCH METHODOLOGY
Overview
Data Mining
Secondary Research
Primary Research
Primary Interviews and Information Gathering Process
Breakdown of Primary Respondents
Forecasting Model
Market Size Estimation
Bottom-Up Approach
Top-Down Approach
Data Triangulation
Validation
3 SECTION III: QUALITATIVE ANALYSIS
MARKET DYNAMICS
Overview
Drivers
Restraints
Opportunities
MARKET FACTOR ANALYSIS
Value chain Analysis
Porter's Five Forces Analysis
Bargaining Power of Suppliers
Bargaining Power of Buyers
Threat of New Entrants
Threat of Substitutes
Intensity of Rivalry
COVID-19 Impact Analysis
Market Impact Analysis
Regional Impact
Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
Japan Plasma Fractionation System Market Segmentation
Japan Plasma Fractionation System Market By Product Type (USD Billion, 2019-2035)
Immunoglobulin
Albumin
Coagulation Factors
Protease Inhibitors
Japan Plasma Fractionation System Market By Application (USD Billion, 2019-2035)
Neurology
Hematology
General Medicine
Immunology
Japan Plasma Fractionation System Market By End User (USD Billion, 2019-2035)
Hospitals
Ambulatory Surgical Centers
Blood Banks
Pharmaceutical Companies
Japan Plasma Fractionation System Market By Technology (USD Billion, 2019-2035)
Centrifugation
Chromatography
Precipitation
Filtration
Japan Plasma Fractionation System Market By Regional (USD Billion, 2019-2035)
North America
Europe
South America
Asia Pacific
Middle East and Africa
Japan Plasma Fractionation System Market SECTION V: COMPETITIVE ANALYSIS
Competitive Landscape
Overview
Competitive Analysis
Market share Analysis
Major Growth Strategy in the plasma fractionation market
Competitive Benchmarking
Leading Players in Terms of Number of Developments in the plasma fractionation market
Key developments and growth strategies
New Product Launch/Service Deployment
Merger & Acquisitions
Joint Ventures
Major Players Financial Matrix
Sales and Operating Income
Major Players R&D Expenditure. 2023
Company Profiles
Takeda Pharmaceutical Company Limited
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Mitsubishi Tanabe Pharma Corporation
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Mitsui Chemicals, Inc.
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Japan Blood Products Organization
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Asahi Kasei Corporation
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Fujifilm Holdings Corporation
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Kaketsuken Co., Ltd.
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Mochida Pharmaceutical Co., Ltd.
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Appendix
References
Related Reports

COMPANIES MENTIONED
Takeda Pharmaceutical Company Limited, Mitsubishi Tanabe Pharma Corporation, Mitsui Chemicals, Inc., Japan Blood Products Organization, Asahi Kasei Corporation, Fujifilm Holdings Corporation, Kaketsuken Co., Ltd., Mochida Pharmaceutical Co., Ltd.

ページTOPに戻る

List of Tables/Graphs

LIST OF FIGURES
FIGURE 1 MARKET SYNOPSIS
FIGURE 2 JAPAN PLASMA FRACTIONATION MARKET ANALYSIS BY APPLICATION
FIGURE 3 JAPAN PLASMA FRACTIONATION MARKET ANALYSIS BY PRODUCT TYPE
FIGURE 4 JAPAN PLASMA FRACTIONATION MARKET ANALYSIS BY END USER
FIGURE 5 JAPAN PLASMA FRACTIONATION MARKET ANALYSIS BY TECHNOLOGY
FIGURE 6 KEY BUYING CRITERIA OF PLASMA FRACTIONATION MARKET
FIGURE 7 RESEARCH PROCESS OF MRFR
FIGURE 8 DRO ANALYSIS OF JAPAN PLASMA FRACTIONATION MARKET
FIGURE 9 DRIVERS IMPACT ANALYSIS: JAPAN PLASMA FRACTIONATION MARKET
FIGURE 10 RESTRAINTS IMPACT ANALYSIS: JAPAN PLASMA FRACTIONATION MARKET
FIGURE 11 SUPPLY / VALUE CHAIN: JAPAN PLASMA FRACTIONATION MARKET
FIGURE 12 JAPAN PLASMA FRACTIONATION MARKET, BY APPLICATION, 2024 (% SHARE)
FIGURE 13 JAPAN PLASMA FRACTIONATION MARKET, BY APPLICATION, 2024 TO 2035 (USD Million)
FIGURE 14 JAPAN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2024 (% SHARE)
FIGURE 15 JAPAN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
FIGURE 16 JAPAN PLASMA FRACTIONATION MARKET, BY END USER, 2024 (% SHARE)
FIGURE 17 JAPAN PLASMA FRACTIONATION MARKET, BY END USER, 2024 TO 2035 (USD Million)
FIGURE 18 JAPAN PLASMA FRACTIONATION MARKET, BY TECHNOLOGY, 2024 (% SHARE)
FIGURE 19 JAPAN PLASMA FRACTIONATION MARKET, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
FIGURE 20 BENCHMARKING OF MAJOR COMPETITORS

LIST OF TABLES
LIST OF ASSUMPTIONS
Japan PLASMA FRACTIONATION MARKET SIZE ESTIMATES; FORECAST
TABLE 1 BY APPLICATION, 2026-2035 (USD Million)
TABLE 2 BY APPLICATION, 2026-2035 (USD Million)
TABLE 3 BY PRODUCT TYPE, 2026-2035 (USD Million)
TABLE 4 BY PRODUCT TYPE, 2026-2035 (USD Million)
TABLE 5 BY END USER, 2026-2035 (USD Million)
TABLE 6 BY END USER, 2026-2035 (USD Million)
TABLE 7 BY TECHNOLOGY, 2026-2035 (USD Million)
TABLE 8 BY TECHNOLOGY, 2026-2035 (USD Million)
PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
ACQUISITION/PARTNERSHIP